首页> 外文期刊>ACS Chemical Biology >Microfluidic Mobility Shift Profiling of Lysine Acetyltransferases Enables Screening and Mechanistic Analysis of Cellular Acetylation Inhibitors
【24h】

Microfluidic Mobility Shift Profiling of Lysine Acetyltransferases Enables Screening and Mechanistic Analysis of Cellular Acetylation Inhibitors

机译:赖氨酸乙酰转移酶的微流淌移动谱分析使细胞乙酰化抑制剂的筛选和机理分析成为可能。

获取原文
获取原文并翻译 | 示例
           

摘要

Lysine acetyltransferases (KATs) are critical regulators of signaling in many diseases, including cancer. A major challenge in establishing the targetable functions of KATs in disease is a lack of well characterized, cell-active KAT inhibitors. To confront this challenge, here we report a microfluidic mobility shift platform for the discovery and characterization of small molecule KAT inhibitors. Novel fluorescent peptide substrates were developed for four well-known KAT enzymes (p300, Crebbp, Morf, and GcnS). Enzyme-catalyzed acetylation alters the electrophoretic mobility of these peptides in a microfluidic chip, allowing facile and direct monitoring of KAT activity. A pilot screen was used to demonstrate the utility of microfluidic mobility shift profiling to identify known and novel modulators of KAT activity. Real-time kinetic monitoring of KAT activity revealed that garcinol, a natural product KAT inhibitor used in cellular studies, exhibits time-dependent and detergent-sensitive inhibition, consistent with an aggregation-based mechanism. In contrast, the cell permeable bisubstrate inhibitor Tat-CoA exhibited potent and time-independent KAT inhibition, highlighting its potential utility as a cellular inhibitor of KAT activity. These studies define microfluidic mobility shift profiling as a powerful platform for the discovery and characterization of small molecule inhibitors of KAT activity, and provide mechanistic insights potentially important for the application of KAT inhibitors in cellular contexts.
机译:赖氨酸乙酰基转移酶(KAT)是许多疾病(包括癌症)中信号传导的关键调节剂。在疾病中建立KAT的可靶向功能的主要挑战是缺乏特征明确的,具有细胞活性的KAT抑制剂。为了应对这一挑战,我们在此报告了一种用于发现和表征小分子KAT抑制剂的微流淌度迁移平台。针对四种著名的KAT酶(p300,Crebbp,Morf和GcnS)开发了新型荧光肽底物。酶催化的乙酰化作用会改变这些肽在微流控芯片中的电泳迁移率,从而可以轻松,直接地监控KAT活性。使用先导筛选来证明微流体迁移率变化图谱的用途,以鉴定已知和新颖的KAT活性调节剂。对KAT活性的实时动力学监测表明,在细胞研究中使用的天然产物KAT抑制剂garcinol具有时间依赖性和去污剂敏感性抑制作用,与​​基于聚集的机制一致。相反,可渗透细胞的双底物抑制剂Tat-CoA表现出强效且不依赖时间的KAT抑制作用,突显了其作为KAT活性的细胞抑制剂的潜在用途。这些研究将微流体迁移率变化分析定义为发现和表征KAT活性小分子抑制剂的强大平台,并提供了对于在细胞环境中应用KAT抑制剂潜在重要的机理性见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号